<DOC>
	<DOCNO>NCT00463697</DOCNO>
	<brief_summary>This study involve use new compound , GW642444 develop treatment asthma chronic obstructive pulmonary disease ( COPD ) . It work act cell lung , cause muscle around lung relax open good ( bronchodilation ) , make breathe easy . When medicine make form ready give patient , active ingredient often prepare another ingredient call salt help make stable , inactive ingredient often add . Inactive ingredient might use help medicine work well , make easy produce medicine , make easy get accurate dose medicine . In previous study study drug give dry powder contain either `` H '' salt ( inactive ingredient lactose ) , contain `` M '' salt ( inactive ingredient lactose cellobiose octaacetate ) . The `` M '' salt form study drug alter contain lactose new inactive ingredient call magnesium stearate ( instead cellobiose octaacetate ) . Participants study receive `` H '' salt ( GW642444H ) new `` M '' salt ( GW642444M ) contain magnesium stearate . This study first time new `` M '' salt form study drug give asthmatic patient .</brief_summary>
	<brief_title>A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion criterion : male female ( nonchildbearing potential ) 18 70 year History stable mild moderate asthma non smoker currently take daily dos inhale fluticasone propionate 200 500 mcg ( equivalent ) body weight &gt; 50 kg BMI 1929.9 kg/m2 normal ECG assessment Exclusion criterion : history significant disease history life threaten asthma recent respiratory tract infection recent change asthma medication treatment high dose inhale corticosteroid oral corticosteroid recent participation another trial history drug alcohol abuse know allergy ( exclude asthma ) recent blood donation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>GW642444 ,</keyword>
	<keyword>magnesium stearate ,</keyword>
	<keyword>asthmatic patient</keyword>
</DOC>